You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ADCC

Showing 26 - 50 of 205
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ependymoma, Recurrent Childhood, Ependymoma Trial in Denver, Orlando (Granulocyte Macrophage Colony Stimulation Factor)

Active, not recruiting
  • Ependymoma, Recurrent Childhood
  • Ependymoma
  • Granulocyte Macrophage Colony Stimulation Factor
  • Denver, Colorado
  • +1 more
Feb 8, 2022

HIV Infection Trial in New York (Colonoscopy)

Not yet recruiting
  • HIV Infection
  • Colonoscopy
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Dec 7, 2022

Circulating Cluster of Differentiation 4 Positive 28 Null T

Not yet recruiting
  • Autoimmune Hemolytic Anemia
    • (no location specified)
    Jan 31, 2023

    SARS-CoV-2-specific Immunity in Individuals Who Have Recovered

    Active, not recruiting
    • SARS-CoV-2
    • COVID-19
    • Sample collection
    • Birmingham, Alabama
    • +52 more
    Sep 3, 2021

    Ebola Sudan Virus Disease Trial (rVSV?G-SEBOV-GP Vaccine or Placebo)

    Not yet recruiting
    • Ebola Sudan Virus Disease
    • rVSV∆G-SEBOV-GP Vaccine or Placebo
    • (no location specified)
    Feb 10, 2023

    Solid Tumors Trial (SPX-101)

    Not yet recruiting
    • Solid Tumors
    • SPX-101
    • (no location specified)
    Feb 8, 2022

    Chronic Lymphocytic Leukemia, Minimal Residual Disease Trial in Bath (Exercise trial)

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia
    • Minimal Residual Disease
    • Exercise trial
    • Bath, Bath & Northeast Somerset, United Kingdom
    • +1 more
    Oct 20, 2021

    Non Hodgkin Lymphoma Trial in United Kingdom (R-CHOP + acalabrutinib)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • R-CHOP + acalabrutinib
    • Southampton, Hampshire, United Kingdom
    • +6 more
    Oct 26, 2022

    HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

    Not yet recruiting
    • HIV-1-infection
    • VRC07-523LS
    • +7 more
    • Pathum Wan, Bangkok, Thailand
    • +1 more
    Mar 8, 2023

    HIV Trial in Johannesburg (CH505TF gp120, GLA-SE adjuvant, Placebo)

    Recruiting
    • HIV Infections
    • CH505TF gp120
    • +2 more
    • Johannesburg, Gauteng, South Africa
      Perinatal HIV Research Unit (PHRU), Soweto CRS
    Apr 29, 2022

    Colon Cancer, Pancreatic Cancer, Cholangiocarcinoma Trial run by the National Cancer Institute (NCI) (MVT-5873, pancreatectomy

    Completed
    • Colon Cancer
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 30, 2022

    Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

    Not yet recruiting
    • Immune Thrombocytopenia
    • Treatment
    • Obinutuzumab Injection [Gazyva]
    • Tianjin, China
      Chinese Academy of Medical Science and Blood Disease Hospital
    Aug 9, 2023

    HIV/AIDS Trial in Bangkok (N-803)

    Recruiting
    • HIV/AIDS
    • Bangkok, Thailand
      Thai Red Cross AIDS Research Centre
    Oct 4, 2021

    Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

    Completed
    Has Results
    • Adult T-Cell Lymphoma/Leukemia
    • +2 more
    • Recombinant human Interleukin-15 (rhIL-15)
    • Mogamulizumab
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 9, 2022

    HIV Trial in Kericho (Env-C Plasmid DNA, HIV Env gp145 C.6980 protein, Rehydragel®)

    Active, not recruiting
    • HIV Infections
    • Env-C Plasmid DNA
    • +6 more
    • Kericho, Kenya
      Kenya Medical Research Institute/Walter Reed Project, Clinical R
    Feb 25, 2022

    RR DLBCL; PD-1; CD20 Trial (F520+F007)

    Not yet recruiting
    • RR DLBCL; PD-1; CD20
    • (no location specified)
    Dec 17, 2021

    B Cell Lymphoma Trial in United Kingdom (Varlilumab)

    Active, not recruiting
    • B Cell Lymphoma
    • Manchester, United Kingdom
    • +3 more
    Oct 26, 2022

    Multiple Myeloma Trial in Boston (CIML NK Cells plus KP1237 and low dose IL-2)

    Recruiting
    • Multiple Myeloma
    • CIML NK Cells plus KP1237 and low dose IL-2
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 18, 2022

    NSCLC, Carcinoma, Renal Cell, Esophageal Squamous Cell Carcinoma Trial (QEQ278)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +3 more
    • QEQ278
    • (no location specified)
    Jul 14, 2022

    Metastatic Breast Cancer Trial (Pertuzumab (ZRC-3277), Pertuzumab (Perjeta®))

    Not yet recruiting
    • Metastatic Breast Cancer
    • Pertuzumab (ZRC-3277)
    • Pertuzumab (Perjeta®)
    • (no location specified)
    Jul 11, 2022

    HIV, HIV/AIDS, HIV-1 Infection Trial in Philadelphia (Pegylated Interferon alpha 2b (peg-IFN-a2b), 3BNC117 + 10-1074)

    Unknown status
    • HIV
    • +2 more
    • Pegylated Interferon alpha 2b (peg-IFN-α2b)
    • 3BNC117 + 10-1074
    • Philadelphia, Pennsylvania
    • +1 more
    Jun 22, 2021

    NonHodgkin's Lymphoma Refractory Trial in El Segundo (N803, CD19t-haNK suspension, Cyclophosphamide)

    Not yet recruiting
    • NonHodgkin's Lymphoma Refractory
    • El Segundo, California
      CSSIFM
    Nov 9, 2022

    Gastric Cancer, Gastroesophageal-junction Cancer Trial (IBI315, Oxaliplatin, Capecitabine)

    Not yet recruiting
    • Gastric Cancer
    • Gastroesophageal-junction Cancer
    • (no location specified)
    Nov 2, 2022

    Castration Resistant Prostate Cancer Trial run by the National Cancer Institute (NCI) (Bintrafusp alfa, N-803, BN-Brachyury)

    Not yet recruiting
    • Castration Resistant Prostate Cancer
    • Bintrafusp alfa
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)

    Terminated
    • Neuroblastoma
    • antibody ch14.18
    • +4 more
    • Cologne, Germany
      University of Cologne
    Nov 3, 2022